Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple Psychedelic Compounds For Therapeutic Use Post published:August 12, 2021 Post category:Press Release
Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation Post published:April 29, 2021 Post category:Press Release